Answers are grounded in this paper and cite their sources.
Examines mental health outcomes during COVID-19, suggesting the need for comprehensive support.
COVID-19 (coronavirus disease 2019) is predominantly a respiratory illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was previously known as the 2019 novel coronavirus. The illness was first noticed in late 2019 and soon spread around the world, causing widespread mortality with case fatality rates of 0.06% in Singapore, 1.37% in Australia, 14.5% in Italy and 19.1% in France in late June 2020. In mid June, five months after the alarm about SARS-CoV-2 was first raised, there were more than 8.65 million confirmed cases and 460,000 deaths worldwide, with numbers still rapidly rising in some countries. As of 21 June 2020, Singapore has confirmed more than 41,800 cases of COVID-19 and had 26 deaths over the same period. he route of transmission and infectivity period of COVID-19 are still being understood. The main mode of transmission is via respiratory droplets from coughs, sneezes and speech onto mucous membranes. Touching a contaminated surface followed by the mucous membranes may contribute to transmission. Airborne transmission is also a risk in aerosol-generating procedures such as airway intubation and nebulisation. The incubation period is up to two weeks with a median of five days. The infectiousness of the virus is high 2.3 days prior to the onset of symptoms and declines after 7-10 days of symptoms. In a subset of asymptomatic patients, infectivity is likely to be lower based on our understanding of the route of transmission.
No takes yet. Share an insight, caveat, or question.
Sim et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: